title: The erythroid/myeloid lineage fate paradigm takes a new player.
authors.affiliation: Division of Hematology/Oncology, Children's Hospital Boston, Howard Hughes Medical Institute, Boston, MA, USA.
authors.forename: Jian
authors.initials: J
authors.lastname: Xu
authors.forename: Stuart H
authors.initials: SH
authors.lastname: Orkin
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D050982:GATA1 Transcription Factor / Q000378:metabolism*; D018507:Gene Expression Regulation, Developmental; D008954:Models, Biological; D009687:Nuclear Proteins / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000378:metabolism*; D015534:Trans-Activators / Q000378:metabolism*; D014157:Transcription Factors / Q000378:metabolism*; D015027:Zebrafish; D029961:Zebrafish Proteins / Q000378:metabolism*; D000099232:Proto-Oncogene Protein Spi-1
chemical_list: D050982:GATA1 Transcription Factor; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; D015534:Trans-Activators; D014157:Transcription Factors; D029961:Zebrafish Proteins; D000099232:Proto-Oncogene Protein Spi-1; C494691:gata1a protein, zebrafish; C093517:transcriptional intermediary factor 1